Advisors Capital Management, LLC Novartis Ag Transaction History

Advisors Capital Management, LLC

  • $6.15 Billion
  • Q3 2024

A detailed history of Advisors Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Advisors Capital Management, LLC holds 43,102 shares of NVS stock, worth $4.47 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
43,102
Previous 42,736 0.86%
Holding current value
$4.47 Million
Previous $4.55 Million 8.97%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $38,843 - $44,245
366 Added 0.86%
43,102 $4.96 Million
Q2 2024

Aug 09, 2024
BUY
$92.57 - $107.37 $353,247 - $409,723
3,816 Added 9.8%
42,736 $4.55 Million
Q1 2024

May 06, 2024
BUY
$95.27 - $108.47 $169,199 - $192,642
1,776 Added 4.78%
38,920 $3.77 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $12,179 - $13,403
-132 Reduced 0.35%
37,144 $3.75 Million
Q3 2023

Nov 15, 2023
BUY
$94.73 - $105.13 $164,261 - $182,295
1,734 Added 4.88%
37,276 $3.8 Million
Q2 2023

Aug 03, 2023
BUY
$92.52 - $104.91 $104,270 - $118,233
1,127 Added 3.27%
35,542 $3.59 Million
Q1 2023

May 04, 2023
BUY
$80.03 - $92.81 $324,201 - $375,973
4,051 Added 13.34%
34,415 $3.17 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $96,326 - $117,963
-1,275 Reduced 4.03%
30,364 $2.76 Million
Q3 2022

Nov 16, 2022
BUY
$74.61 - $87.26 $202,416 - $236,736
2,713 Added 9.38%
31,639 $2.64 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $156,691 - $182,437
1,946 Added 7.21%
28,926 $2.45 Million
Q1 2022

May 10, 2022
BUY
$80.11 - $90.62 $322,923 - $365,289
4,031 Added 17.57%
26,980 $2.37 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $5.75 Million - $6.36 Million
-72,166 Reduced 75.87%
22,949 $2.01 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $460,748 - $536,018
5,634 Added 6.3%
95,115 $7.78 Million
Q2 2021

Aug 02, 2021
SELL
$85.24 - $94.15 $4.06 Million - $4.48 Million
-47,620 Reduced 34.73%
89,481 $8.16 Million
Q1 2021

May 12, 2021
BUY
$83.5 - $98.47 $277,971 - $327,806
3,329 Added 2.49%
137,101 $11.7 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $453,196 - $548,166
5,805 Added 4.54%
133,772 $12.6 Million
Q3 2020

Nov 05, 2020
SELL
$82.14 - $91.0 $258,330 - $286,195
-3,145 Reduced 2.4%
127,967 $11.1 Million
Q2 2020

Aug 18, 2020
SELL
$80.93 - $91.1 $6.84 Million - $7.7 Million
-84,538 Reduced 39.2%
131,112 $11.5 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $189,748 - $265,841
2,685 Added 1.26%
215,650 $17.8 Million
Q4 2019

Jan 10, 2020
BUY
$84.35 - $95.37 $890,567 - $1.01 Million
10,558 Added 5.22%
212,965 $20.2 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $1.03 Million - $1.14 Million
12,045 Added 6.33%
202,407 $17.6 Million
Q2 2019

Aug 15, 2019
BUY
$75.4 - $92.8 $756,111 - $930,598
10,028 Added 5.56%
190,362 $17.4 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $27,793 - $31,789
369 Added 0.21%
180,334 $17.3 Million
Q4 2018

Jan 17, 2019
BUY
$73.66 - $82.02 $1.32 Million - $1.47 Million
17,977 Added 11.1%
179,965 $15.4 Million
Q3 2018

Oct 10, 2018
SELL
$66.94 - $77.43 $254,037 - $293,846
-3,795 Reduced 2.29%
161,988 $14 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $1.61 Million - $1.82 Million
24,745 Added 17.54%
165,783 $12.5 Million
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $9.18 Million - $11 Million
-130,463 Closed
0 $0
Q4 2017

Jan 24, 2018
SELL
$72.33 - $77.64 $123,539 - $132,609
-1,708 Reduced 1.29%
130,463 $11 Million
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $9.8 Million - $10.2 Million
132,171
132,171 $11.3 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email